Avella Recalls Hydromorphone Bags Due to Sterility Assurance Concerns
Avella of Deer Valley, Inc. is recalling 360 bags of Hydromorphone in NS due to a lack of assurance of sterility. The product was distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of sterility assurance for an injectable drug, which poses a significant risk of serious injury or infection.
Plain-English summary
Avella of Deer Valley, Inc. Store 38 is recalling 360 bags of Hydromorphone (0.2 mg/mL) in NS 100 mL Bag. The recall is being conducted because of a lack of assurance of sterility for the product.
The affected product is prescription-only and was distributed nationwide in the United States. The specific lot number is 8/27/18 0215 22110P, with an expiration date of 12/10/2018.
Consumers and healthcare providers should stop using the affected product and contact the recalling firm or their healthcare provider for further instructions.
The recalled product
- Product
- Hydromorphone (0.2 mg/mL) in NS 100 mL Bag, Rx only, Advanced Pharma, Inc. d/b/a Avella of Houston, and Avella of Deer Valley, Inc. #38
- Manufacturer
- Avella of Deer Valley, Inc. Store 38
- Category
- Drug — Injectable
- Affected units
- 360
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 8/27/18 0215 22110P
- Exp 12/10/2018
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by Avella of Deer Valley, Inc. Store 38 under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Avella of Deer Valley, Inc. Store 38
See all →- SevereAvella Recalls Povidone Iodine Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2019-10-30
- SevereAvella Recalls Bevacizumab Prefilled Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-06-05
- ModerateAvella recalls magnesium sulfate bags with incorrect barcode expiration dates
FDA (Drugs) · 2019-02-20
- ModerateAvella recalls magnesium sulfate bags with incorrect barcode expiration dates
FDA (Drugs) · 2019-02-20
- ModerateAvella Recalls Labetalol Syringes Due to Incorrect Barcode Expiration Dates
FDA (Drugs) · 2019-02-20
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereAvella Recalls Hydromorphone Injection Bags Due to Sterility Concerns
FDA (Drugs) · 2018-07-25
- HighAvella Recalls Hydromorphone Syringes Due to Sterility Concerns
FDA (Drugs) · 2018-07-25
- SevereAvella Recalls Hydromorphone Syringes Due to Sterility Assurance Concerns
FDA (Drugs) · 2018-07-25
- SevereAvella Recalls Morphine Bags Due to Potential Leakage and Sterility Concerns
FDA (Drugs) · 2018-07-25
- SevereAvella Recalls Morphine Syringes Due to Potential Sterility Compromise
FDA (Drugs) · 2018-07-25
- SevereAvella Recalls Norepinephrine Syringes Due to Potential Sterility Compromise
FDA (Drugs) · 2018-07-25